IMPORTANCE: Multiple studies have found an increased prevalence, younger age at onset, and more severe course of glaucoma in people of African descent, but these findings are based on studies conducted outside Africa. OBJECTIVE: To determine the prevalence of glaucoma in an urban West African population of adults. DESIGN AND SETTING: A population-based, cross-sectional study of adults 40 years and older conducted from September 1, 2006, through December 31, 2008, from 5 communities in Tema, Ghana. PARTICIPANTS: Participants from randomly selected clusters underwent a screening examination that consisted of visual acuity, frequency doubling perimetry, applanation tonometry, and optic disc photography. Participants who failed any of these tests were referred for complete examination, including gonioscopy, standard automated perimetry, and stereoscopic optic disc photography. RESULTS: A total of 6806 eligible participants were identified, and 5603 (82.3%) were enrolled in the study. The field examination referred 1869 participants (33.3%) to the clinic examination, and 1538 (82.2%) came for complete examination. A total of 362 participants were identified as having glaucoma of any type and category. Primary open-angle glaucoma was the underlying diagnosis in 342 participants (94.5%). The prevalence of primary open-angle glaucoma was 6.8% overall, increasing from 3.7% among those 40 to 49 years old to 14.6% among those 80 years and older, and was higher in men than in women in all age groups, with an overall male-female prevalence ratio of 1.5. Of the participants with glaucoma, 9 (2.5%) were blind using World Health Organization criteria, and only 12 (3.3%) were aware that they had glaucoma. CONCLUSIONS AND RELEVANCE: The prevalence of glaucoma is higher in this urban West African population than in previous studies of people of East or South African and of non-African descent. Strategies to identify affected persons and effectively manage the burden of glaucoma are needed in West Africa.
IMPORTANCE: Multiple studies have found an increased prevalence, younger age at onset, and more severe course of glaucoma in people of African descent, but these findings are based on studies conducted outside Africa. OBJECTIVE: To determine the prevalence of glaucoma in an urban West African population of adults. DESIGN AND SETTING: A population-based, cross-sectional study of adults 40 years and older conducted from September 1, 2006, through December 31, 2008, from 5 communities in Tema, Ghana. PARTICIPANTS: Participants from randomly selected clusters underwent a screening examination that consisted of visual acuity, frequency doubling perimetry, applanation tonometry, and optic disc photography. Participants who failed any of these tests were referred for complete examination, including gonioscopy, standard automated perimetry, and stereoscopic optic disc photography. RESULTS: A total of 6806 eligible participants were identified, and 5603 (82.3%) were enrolled in the study. The field examination referred 1869 participants (33.3%) to the clinic examination, and 1538 (82.2%) came for complete examination. A total of 362 participants were identified as having glaucoma of any type and category. Primary open-angle glaucoma was the underlying diagnosis in 342 participants (94.5%). The prevalence of primary open-angle glaucoma was 6.8% overall, increasing from 3.7% among those 40 to 49 years old to 14.6% among those 80 years and older, and was higher in men than in women in all age groups, with an overall male-female prevalence ratio of 1.5. Of the participants with glaucoma, 9 (2.5%) were blind using World Health Organization criteria, and only 12 (3.3%) were aware that they had glaucoma. CONCLUSIONS AND RELEVANCE: The prevalence of glaucoma is higher in this urban West African population than in previous studies of people of East or South African and of non-African descent. Strategies to identify affected persons and effectively manage the burden of glaucoma are needed in West Africa.
Authors: Yutao Liu; Michael A Hauser; Stephen K Akafo; Xuejun Qin; Shiroh Miura; Jason R Gibson; Joshua Wheeler; Douglas E Gaasterland; Pratap Challa; Leon W Herndon; Robert Ritch; Sayoko E Moroi; Louis R Pasquale; Christopher A Girkin; Donald L Budenz; Janey L Wiggs; Julia E Richards; Allison E Ashley-Koch; R Rand Allingham Journal: Invest Ophthalmol Vis Sci Date: 2013-09-17 Impact factor: 4.799
Authors: J C Mwanza; D S Grover; D L Budenz; L W Herndon; W Nolan; J Whiteside-de Vos; G Hay-Smith; J R Bandi; K A Bhansali; L A Forbes; W J Feuer; K Barton Journal: Eye (Lond) Date: 2017-04-07 Impact factor: 3.775
Authors: Michael A Hauser; R Rand Allingham; Tin Aung; Carly J Van Der Heide; Kent D Taylor; Jerome I Rotter; Shih-Hsiu J Wang; Pieter W M Bonnemaijer; Susan E Williams; Sadiq M Abdullahi; Khaled K Abu-Amero; Michael G Anderson; Stephen Akafo; Mahmoud B Alhassan; Ifeoma Asimadu; Radha Ayyagari; Saydou Bakayoko; Prisca Biangoup Nyamsi; Donald W Bowden; William C Bromley; Donald L Budenz; Trevor R Carmichael; Pratap Challa; Yii-Der Ida Chen; Chimdi M Chuka-Okosa; Jessica N Cooke Bailey; Vital Paulino Costa; Dianne A Cruz; Harvey DuBiner; John F Ervin; Robert M Feldman; Miles Flamme-Wiese; Douglas E Gaasterland; Sarah J Garnai; Christopher A Girkin; Nouhoum Guirou; Xiuqing Guo; Jonathan L Haines; Christopher J Hammond; Leon Herndon; Thomas J Hoffmann; Christine M Hulette; Abba Hydara; Robert P Igo; Eric Jorgenson; Joyce Kabwe; Ngoy Janvier Kilangalanga; Nkiru Kizor-Akaraiwe; Rachel W Kuchtey; Hasnaa Lamari; Zheng Li; Jeffrey M Liebmann; Yutao Liu; Ruth J F Loos; Monica B Melo; Sayoko E Moroi; Joseph M Msosa; Robert F Mullins; Girish Nadkarni; Abdoulaye Napo; Maggie C Y Ng; Hugo Freire Nunes; Ebenezer Obeng-Nyarkoh; Anthony Okeke; Suhanya Okeke; Olusegun Olaniyi; Olusola Olawoye; Mariana Borges Oliveira; Louise R Pasquale; Rodolfo A Perez-Grossmann; Margaret A Pericak-Vance; Xue Qin; Michele Ramsay; Serge Resnikoff; Julia E Richards; Rui Barroso Schimiti; Kar Seng Sim; William E Sponsel; Paulo Vinicius Svidnicki; Alberta A H J Thiadens; Nkechinyere J Uche; Cornelia M van Duijn; José Paulo Cabral de Vasconcellos; Janey L Wiggs; Linda M Zangwill; Neil Risch; Dan Milea; Adeyinka Ashaye; Caroline C W Klaver; Robert N Weinreb; Allison E Ashley Koch; John H Fingert; Chiea Chuen Khor Journal: JAMA Date: 2019-11-05 Impact factor: 56.272
Authors: Pete R Jones; Heiko Philippin; William U Makupa; Matthew J Burton; David P Crabb Journal: Ophthalmic Epidemiol Date: 2019-09-13 Impact factor: 1.648
Authors: Naira Khachatryan; Felipe A Medeiros; Lucie Sharpsten; Christopher Bowd; Pamela A Sample; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Atsuya Miki; Na'ama Hammel; Linda M Zangwill Journal: Am J Ophthalmol Date: 2015-01-15 Impact factor: 5.258